ResApp crashes on study results

09/08/2017 - 15:41

Bookmark

Save articles for future reference.

Shares in medical tech company ResApp Health plummeted 77 per cent today on disappointing results of a clinical study on its ResAppDx technology.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options